Pfizer, Inc. filed its notice and plan earlier this month to conduct an initial public offering (IPO) for its animal health business by notifying the U.S. Securities & Exchange Commission that it would offer as much as 20 percent of the unit’s Class A common stock to the public. The offering could happen sometime during first half of 2013.
Pfizer Animal Health has a broad portfolio of products that are important to poultry, livestock, horses, and companion animals. The name of the new spin-off, stand alone company will be Zoetis™. The name derives from zoetic, meaning “pertaining to life.” Pfizer noted that it may sell its remaining 80 percent interest in Zoetis at some time after the IPO is launched.
Pfizer Animal Health is an allied industry member of the National Chicken Council.
